StonvexLoading…
StonvexStonvexStonvexCore line items from WHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.27B | $15.52B | $11.43B | $7.39B |
Operating Income | $18.00M | $838.00M | $595.00M | $389.00M |
Net Income | $-82.00M | $318.00M | $210.00M | $137.00M |
EPS (Diluted) | $-1.43 | $5.66 | $3.74 | $2.45 |
Total Assets | $16.18B | $16.00B | $16.89B | $16.76B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $626.00M | $669.00M | $934.00M | $1.07B |
Free Cash Flow OCF − CapEx | $-895.00M | $81.00M | $-908.00M | $-856.00M |
Shares Outstanding | 65.00M | 56.00M | 56.00M | 55.00M |